23.53 0.00 (0.00%)
After hours: 4:33PM EDT
|Bid||23.64 x 900|
|Ask||23.65 x 800|
|Day's Range||23.46 - 23.92|
|52 Week Range||21.06 - 49.32|
|Beta (3Y Monthly)||2.15|
|PE Ratio (TTM)||5.30|
|Forward Dividend & Yield||1.00 (4.74%)|
|1y Target Est||N/A|
President and CEO of The Chemours Co (NYSE:CC) Mark P Vergnano bought 44,000 shares of CC on 06/10/2019 at an average price of $23.17 a share.
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors' favor when it comes to beating the market, […]
is promoting its chief operating officer Mark Newman to a newly created position of chief operating officer, said the chemical company Tuesday. As the company's COO, Newman will be responsible for Chemours' Titanium Technologies, Fluoroproducts and Chemical Solutions businesses. Another Chemours' executive, Sameer Ralhan, vice president of business finance and treasurer, will take on the CFO job.
Chemours Co. said late Tuesday it named Mark Newman to the newly created role of chief operating officer, and promoted its vice president of business finance and treasurer Sameer Ralhan to chief financial officer and treasurer. Both executives report to Chief Executive Mark Vergnano, and the promotions are effective immediately. Chemical company Chemours, the maker of Teflon, was spun off DuPont and went public in 2015.
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Another state has filed a lawsuit against regional chemical manufacturers DowDuPont and Chemours over contamination caused by dangerous chemicals. New Hamphire's governor, attorney general and department of environmental services commissioner announced Wednesday they've filed two separate lawsuits against DowDuPont and its spinoff Chemours, along with other manufacturers of PFAS, a family of chemicals used to create products like firefighting foam and Teflon. The complaint comes about two weeks after New Jersey filed its own lawsuit in New Jersey Superior Court against the same group of manufacturers New Hampshire is targeting, which includes Tyco Fire Products LP, based in North Wales, as well as Chemguard Inc., Buckeye Fire Equipment Co., Kidde-Fenwal Inc. and National Foam Inc. The lawsuits allege that the companies produced the chemicals, which are linked to cancers and other serious health issues, knowing they could seep into natural resources and harm residents.
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...
A Delaware judge has ordered the unsealing of a complaint filed by chemical manufacturer Chemours against the DuPont Co., which spun off Chemours in 2015, and chastised attorneys for the secrecy surrounding the dispute. Chemours then failed to comply with a court rule requiring the filing of a redacted, public version of the complaint within three days. The redacted version of the 64-page complaint — which was filed shortly after The Associated Press pointed out the expiration of the deadline and asked the court to unseal the filing — is almost entirely blacked out.
Chemours Co (NYSE: CC) stock traded higher by more than 7 percent on Tuesday after selling off by 8 percent over the previous week. It’s not just stock buyers that are making big bullish bets on a Chemours bounce. The largest Monday trade was a purchase of 2,500 Chemours call options at a $29 strike price that expire on July 19.
DowDuPont stock dropped 17% through last week since the company reported earnings. DowDuPont’s performance is an outlier in the industry, too. The reason is more complicated than you might think.
Zacks Value Trader Highlights: General Motors, General Electric, Chemours, Camping World and L Brands
The Wilmington, Delaware-based company said it had profit of 55 cents per share. Earnings, adjusted for one-time gains and costs, were 63 cents per share. The results did not meet Wall Street expectations. ...
Glenview Capital CEO Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.
Glenview Capital's Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.